Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, today announced that Ernest LOUMAYE, M.D., Ph.D., CEO and Co-Founder, Tim ADAMS, CFO, and Mario CORSO, Senior Director Investor Relations will attend the Jefferies Healthcare Conference. Management will be presenting on Thursday June 8th at 08:30 a.m. and will be hosting one-on-one meetings at the Grand Hyatt Hotel in New York City.
About ObsEva
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving ART outcomes. ObsEva is listed on The NASDAQ Global Select Market and is trading under the ticker symbol "OBSV". For more information, please visit www.ObsEva.com
###
Media Contact:
Liz Bryan
Spectrum Science
[email protected]
202-955-6222 x2526
Company Contact:
CEO Office contact
Delphine Renaud
[email protected]
+41 22 552 1550
Investor Contact
Mario Corso
Senior Director, Investor Relations
[email protected]
781-366-5726
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/70181aa5-664e-4bd9-a30f-7dcaa32de878


Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex
Tesla Launches New Model Y Variant in the US Starting at $41,990
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Disney Board Nears CEO Decision as Josh D’Amaro Emerges as Leading Candidate
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Google Cloud and Liberty Global Forge Strategic AI Partnership to Transform European Telecom Services
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 



